Prasterone Market Report – Research, Industry Analysis Reports and Market Demands

Global Prasterone Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report

Buy now

Table of Content

1 Market Overview

1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
- 1.3.1 Overview: Global Prasterone Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 ≥98％
- 1.3.3 Others
1.4 Market Analysis by Application
- 1.4.1 Overview: Global Prasterone Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Medicine
- 1.4.3 Dietary Supplements
- 1.4.4 Skin Care Products
- 1.4.5 Reagents
- 1.4.6 Others
1.5 Global Prasterone Market Size & Forecast
- 1.5.1 Global Prasterone Consumption Value (2021 & 2025 & 2032)
- 1.5.2 Global Prasterone Sales Quantity (2021-2032)
- 1.5.3 Global Prasterone Average Price (2021-2032)

2 Manufacturers Profiles

3 Competitive Environment: Prasterone by Manufacturer

3.1 Global Prasterone Sales Quantity by Manufacturer (2021-2026)
3.2 Global Prasterone Revenue by Manufacturer (2021-2026)
3.3 Global Prasterone Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Prasterone by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Prasterone Manufacturer Market Share in 2025
- 3.4.3 Top 6 Prasterone Manufacturer Market Share in 2025
3.5 Prasterone Market: Overall Company Footprint Analysis
- 3.5.1 Prasterone Market: Region Footprint
- 3.5.2 Prasterone Market: Company Product Type Footprint
- 3.5.3 Prasterone Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

4.1 Global Prasterone Market Size by Region
- 4.1.1 Global Prasterone Sales Quantity by Region (2021-2032)
- 4.1.2 Global Prasterone Consumption Value by Region (2021-2032)
- 4.1.3 Global Prasterone Average Price by Region (2021-2032)
4.2 North America Prasterone Consumption Value (2021-2032)
4.3 Europe Prasterone Consumption Value (2021-2032)
4.4 Asia-Pacific Prasterone Consumption Value (2021-2032)
4.5 South America Prasterone Consumption Value (2021-2032)
4.6 Middle East & Africa Prasterone Consumption Value (2021-2032)

5 Market Segment by Type

5.1 Global Prasterone Sales Quantity by Type (2021-2032)
5.2 Global Prasterone Consumption Value by Type (2021-2032)
5.3 Global Prasterone Average Price by Type (2021-2032)

6 Market Segment by Application

6.1 Global Prasterone Sales Quantity by Application (2021-2032)
6.2 Global Prasterone Consumption Value by Application (2021-2032)
6.3 Global Prasterone Average Price by Application (2021-2032)

7 North America

7.1 North America Prasterone Sales Quantity by Type (2021-2032)
7.2 North America Prasterone Sales Quantity by Application (2021-2032)
7.3 North America Prasterone Market Size by Country
- 7.3.1 North America Prasterone Sales Quantity by Country (2021-2032)
- 7.3.2 North America Prasterone Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

8.1 Europe Prasterone Sales Quantity by Type (2021-2032)
8.2 Europe Prasterone Sales Quantity by Application (2021-2032)
8.3 Europe Prasterone Market Size by Country
- 8.3.1 Europe Prasterone Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Prasterone Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

9.1 Asia-Pacific Prasterone Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Prasterone Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Prasterone Market Size by Region
- 9.3.1 Asia-Pacific Prasterone Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Prasterone Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

10.1 South America Prasterone Sales Quantity by Type (2021-2032)
10.2 South America Prasterone Sales Quantity by Application (2021-2032)
10.3 South America Prasterone Market Size by Country
- 10.3.1 South America Prasterone Sales Quantity by Country (2021-2032)
- 10.3.2 South America Prasterone Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

11.1 Middle East & Africa Prasterone Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Prasterone Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Prasterone Market Size by Country
- 11.3.1 Middle East & Africa Prasterone Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Prasterone Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

12.1 Prasterone Market Drivers
12.2 Prasterone Market Restraints
12.3 Prasterone Trends Analysis
12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

13.1 Raw Material of Prasterone and Key Manufacturers
13.2 Manufacturing Costs Percentage of Prasterone
13.3 Prasterone Production Process
13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
14.2 Prasterone Typical Distributors
14.3 Prasterone Typical Customers

15 Research Findings and Conclusion

16 Appendix

16.1 Methodology
16.2 Research Process and Data Source

Description

According to our (Global Info Research) latest study, the global Prasterone market size was valued at US$ 51.56 million in 2025 and is forecast to a readjusted size of US$ 82.38 million by 2032 with a CAGR of 7.0% during review period.
Prasterone, the synthetic equivalent of endogenous dehydroepiandrosterone (DHEA), has emerged as a key player in the field of hormone-based therapies. Traditionally recognized for its role in alleviating menopausal symptoms—particularly moderate to severe dyspareunia—it is increasingly being investigated for broader applications including anti-aging, cognitive enhancement, and even immune modulation. With its ability to convert locally into estrogens and androgens, prasterone represents a unique therapeutic modality with minimal systemic exposure, garnering interest from both the medical and wellness communities.
Research institutions and pharmaceutical companies are increasingly exploring prasterone’s potential in areas beyond its current indications, including neuroprotection and metabolic modulation. This diversification is expected to broaden the market scope over the next several years.
In developed markets like the United States and Europe, prasterone is gaining traction as part of a broader trend toward hormone replacement therapies. The aging population’s growing need for treatments that address not only physical but also sexual and cognitive declines is fuelling this demand.
With DHEA levels naturally declining after age 30—more rapidly in women—the need for interventions that restore hormonal balance is becoming more pronounced. This demographic shift is a primary market driver for prasterone-based therapies.
This report is a detailed and comprehensive analysis for global Prasterone market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Prasterone market size and forecasts, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/kg), 2021-2032
Global Prasterone market size and forecasts by region and country, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/kg), 2021-2032
Global Prasterone market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/kg), 2021-2032
Global Prasterone market shares of main players, shipments in revenue ($ Million), sales quantity (kg), and ASP (US$/kg), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Prasterone
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Prasterone market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Yicheng Goto Pharmaceuticals Co.,Ltd., Junye Pharmaceutical Co., Ltd., Zhejiang Shenzhou Pharmaceutical Co., Ltd., Hubei Zhuxi Humanwell Pharmaceutical Co., Ltd., Jiangsu Jiaerke Pharmaceuticals Group Corp., Hubei Dan’ao Pharmaceutical Co., Ltd., Wudang Antai Pharmaceutical Co., Ltd., Shandong Saito Biotechnology Co., Ltd., NutriScience Innovations, LLC, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Prasterone market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
≥98％
Others
Market segment by Application
Medicine
Dietary Supplements
Skin Care Products
Reagents
Others
Major players covered
Yicheng Goto Pharmaceuticals Co.,Ltd.
Junye Pharmaceutical Co., Ltd.
Zhejiang Shenzhou Pharmaceutical Co., Ltd.
Hubei Zhuxi Humanwell Pharmaceutical Co., Ltd.
Jiangsu Jiaerke Pharmaceuticals Group Corp.
Hubei Dan’ao Pharmaceutical Co., Ltd.
Wudang Antai Pharmaceutical Co., Ltd.
Shandong Saito Biotechnology Co., Ltd.
NutriScience Innovations, LLC
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Prasterone product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Prasterone, with price, sales quantity, revenue, and global market share of Prasterone from 2021 to 2026.
Chapter 3, the Prasterone competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Prasterone breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Prasterone market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Prasterone.
Chapter 14 and 15, to describe Prasterone sales channel, distributors, customers, research findings and conclusion.

Buy now